Teva gets patent for invention related to multiple sclerosis drug

Stuart SchlossmanOral MS Medications

April 16, 2016

The company claims that the pharmaceutical composition in the product, related to multiple sclerosis drug Laquinimod, provides superior stabilisation

Israel-based Teva Pharmaceuticals has received patent approval for a product related to multiple sclerosis drug Laquinimod. According to reports, Laquinimod is developed by Teva Pharma in collaboration with Active Biotech AB, a Swedish biotechnology company which has focus on neurodegenerative/ inflammatory diseases and cancer.
According to Active Biotech, laquinimod is a compound under development for the treatment of multiple sclerosis and Huntington’s disease and the company has an agreement with Teva covering the development and commercialisation of the drug.










                                            ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

MS Views and News 

Providing educational information and resources for those affected by MS
Keep current with Multiple Sclerosis news and information 
To opt-in (sign-up) at our website: click here – thank you
.===================================
Visit our MS Learning Channel on YouTube: http://www.youtube.com/msviewsandnews